COMMUNIQUÉS West-GlobeNewswire

NOTICE TO CONVENE ORDINARY GENERAL MEETING
20/03/2019
INDKALDELSE TIL ORDINÆR GENERALFORSAMLING NOTICE TO CONVENE ORDINARY GENERAL MEETING KALLELSE TILL ÅRSSTÄMMA Der indkaldes herved til ordinær generalforsamling i Oncology Venture A/S (“ Selskabet “): Notice is hereby [...]
Galapagos increases share capital through warrant exercises
20/03/2019
Mechelen, Belgium; 20 March 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 149,370 new ordinary [...]
Portola Pharmaceuticals’ Co-Founder Dr. Charles Homcy Retires from the Company’s Board of Directors
20/03/2019
SOUTH SAN FRANCISCO, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that on March 15, 2019 Charles Homcy, M.D., informed the Board of his decision to retire [...]
PROJECT HOPE RESPONDS TO DEADLY MOZAMBIQUE CYCLONE
20/03/2019
“Cyclone Idai was deadly. If we don’t act now, the aftermath will be deadlier.” Millwood, Virginia, March 20, 2019 (GLOBE NEWSWIRE) -- Project HOPE is on the ground in Mozambique working as quickly as possible to gather [...]
Kane Biotech Schedules Full Year 2018 Earnings Conference Call and Business Update
20/03/2019
Conference Call to be held Tuesday, March 26 at 4:00pm ET WINNIPEG, Manitoba, March 20, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), is pleased to announce today that it [...]
Rockwell Medical, Inc. to Present at Sidoti & Company LLC Spring 2019 Investor Conference
20/03/2019
WIXOM, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the Sidoti & [...]
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
20/03/2019
Provides Initial Response to FDA SANTA BARBARA, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra" or the “Company”), today announced it has provided an [...]
Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019
20/03/2019
BERKELEY, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]
Sharecare announces winners of inaugural Sharecare Awards
20/03/2019
ATLANTA, March 20, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, has announced the recipients of its first-ever Sharecare Awards , which recognize [...]
Corcept Therapeutics Announces Poster Presentations at the 2019 Annual Meeting of the Endocrine Society Meeting
20/03/2019
MENLO PARK, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering
20/03/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Establishment Labs Reports Fourth Quarter and Full Year 2018 Financial Results
20/03/2019
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
CB2 Insights Clarifies Terms of Agreement to Acquire MedEval LLC
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services across the cannabis value [...]
Stryker announces Annual Meeting of Shareholders
20/03/2019
Kalamazoo, Michigan, March 20, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2019 Annual Meeting of Shareholders is scheduled as follows: May 1, 2019 – 2:00 p.m. Eastern Time Radisson Plaza Hotel & [...]
Emisphere Development Update
20/03/2019
ROSELAND, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today it has submitted two New Drug Applications (“NDA”) to the US Food and Drug Administration (“FDA”) for oral semaglutide, a once-daily oral [...]
VitalHub Corp. Announces Closing of Acquisition of the Assets of the Oak Group, Inc.
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce that it has completed the acquisition of (the “Acquisition”) substantially all of the assets [...]
SPINEWAY : Projet d’acquisition majeure en Amérique Latine
20/03/2019
Projet d’acquisition majeure en Amérique Latine Spineway annonce avoir conclu une promesse d’achat 1 visant à prendre une participation au capital (à terme majoritaire puis exclusive in fine ) d’un groupe hospitalier [...]
Oncology Venture publishes the Annual Report for 2018
20/03/2019
Press Release Hørsholm, Denmark and Cambridge, MA, US, March 20, 2019 – Oncology Venture A/S (“OV” or the Company) today publishes the Annual Report for 2018. The Annual Report is available as an attached document and [...]
Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019
20/03/2019
WALTHAM, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

Pages